Hemedex
Hemedex is a private medical device company that commercializes FDA-cleared thermal diffusion technology from MIT to provide the Bowman Perfusion Monitor, the only bedside system delivering absolute real-time cerebral blood flow in ml/100g-min. It serves neuro ICUs, neurosurgery ORs, and academic medical centers treating severe brain injury.
- Company typePrivate
- Founded2000
- HeadquartersCambridge, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Hemedex does
Hemedex, Inc. is a privately held medical device company founded in 2000 to commercialize a proprietary thermal diffusion (TD) platform technology conceived at the Massachusetts Institute of Technology for quantifying tissue perfusion at the capillary level. The company is headquartered in Waltham, Massachusetts, and operates as a subsidiary of Thermal Technologies Incorporated. Its flagship product, the Bowman Perfusion Monitor (BPM), is FDA cleared and continuously measures cerebral blood flow in absolute physiological units (ml/100g-min) at the bedside, supported by the QFlow 500 Perfusion Probe (single-patient use, FDA cleared for 10 days in situ, CE Marked) and QFlow 500 Titanium Bolt Kits in Single, Dual, and Quad Lumen configurations that anchor probes through a cranial burr hole. The Quad Lumen configuration integrates up to six intracranial parameters through one bolt, positioning the device as a multimodal neuromonitoring hub.
The company serves primarily neurointensive care units and neurosurgery operating rooms at academic medical centers, Level I/II trauma centers, and community hospitals with neurocritical care capabilities. Primary clinical use cases include detection of ischemia and vasospasm in traumatic brain injury (TBI), subarachnoid hemorrhage (SAH), and other severe brain injuries, plus intraoperative monitoring during cerebrovascular procedures. Secondary use cases extend to organ transplantation and reconstructive microvascular surgery. Hemedex sells through independent sales representatives and a small direct sales team in the US, with no distributor or e-commerce channels. Revenue is generated via capital equipment sales of the BPM console and recurring consumables from single-use probes and bolt kits; pricing is quote-based and not publicly disclosed.
Hemedex firmographics
Firmographics- Name
- Hemedex
- Legal name
- Hemedex, Inc.
- Website
- https://hemedex.com
- Company type
- Private
- Founded year
- 2000
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Hemedex is a private medical device company that commercializes FDA-cleared thermal diffusion technology from MIT to provide the Bowman Perfusion Monitor, the only bedside system delivering absolute real-time cerebral blood flow in ml/100g-min. It serves neuro ICUs, neurosurgery ORs, and academic medical centers treating severe brain injury.
- Ownership category
- akta.pro rank
Hemedex industry classification
Industry- Product category
- Neurocritical Care Perfusion Monitoring Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Hemodynamic Monitoring & Cardiac Diagnostics (Cath Lab, FFR/IVUS/OCT) (HLAHAFAI)
- akta.pro secondary industry
- Stroke & Vascular Neurology (HLAKAIAG)
Keywords
Where Hemedex is headquartered
LocationHeadquarters
- HQ city
- Cambridge
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Hemedex business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales, Infrastructure
Revenue model
- Medical Device Hardware Sales: Hemedex generates revenue from selling medical monitoring equipment including the Bowman Perfusion Monitor, QFlow 500 Perfusion Probes, and QFlow 500 Titanium Bolt Kits. The probe is single patient use (FDA cleared for 10 days in situ) and the bolt is single use, creating recurring consumables revenue alongside capital equipment sales.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | Bowman Perfusion Monitor (BPM) - Capital Equipment |
| Unit Pricing | Pay-as-you-go | QFlow 500 Perfusion Probe - Single Patient Use Consumable |
| Unit Pricing | Pay-as-you-go | QFlow 500 Titanium Bolt Kits - Single Use Accessories |
Go-to-market motion2 records
Distribution channels2 records
Marketing channels5 records
Hemedex product offering
Product offeringCore offering
Hemedex sells the Bowman Perfusion Monitor (BPM), a capital device that continuously quantifies tissue blood flow (perfusion) in absolute physiological units of ml/100g-min via proprietary thermal diffusion technology, together with its single-patient-use QFlow 500 Perfusion Probe and Single, Dual, and Quad Lumen Titanium Bolt Kits for cranial fixation. The system is used by neurosurgeons, neurointensivists, and neurologists in Neuro ICUs and operating rooms to detect cerebral ischemia, vasospasm, and edema in patients with traumatic brain injury, subarachnoid hemorrhage, and other acute brain injuries, and integrates with leading multimodal neuromonitoring platforms.
Product overview
Hemedex provides a complete solution for continuous, real-time measurement of cerebral perfusion in absolute units. The core offering is the Bowman Perfusion Monitor (BPM), which works in conjunction with the QFlow 500 Perfusion Probe, QFlow 500 Titanium Bolt Kits (Single, Dual, and Quad Lumen variants), and an Umbilical Cord. The company was founded in 2000 to commercialize proprietary platform technology conceived at MIT for quantifying tissue perfusion using thermal diffusion. All Hemedex products are FDA cleared, with the Cranial Bolt Kit product line and QFlow 500 Perfusion Probe also CE Marked.
Differentiator
Problem solved
Functional benefit
Brands
- Bowman Perfusion Monitor: The Bowman Perfusion Monitor (BPM) continuously quantifies tissue blood flow (perfusion) in real-time, in absolute physiological units of ml/100g-min.
- QFlow 500 Perfusion Probe
- QFlow 500 Titanium Bolt Kits
Products and services
- Bowman Perfusion Monitor (BPM) Capital monitoring device that continuously quantifies tissue blood flow (perfusion) in real-time in absolute physiological units of ml/100g-min, detecting onset of ischemia and vasospasm for neurosurgery and neurocritical care applications.
- QFlow 500 Perfusion Probe Minimally invasive, flexible radio-opaque catheter that continuously quantifies tissue perfusion using thermal diffusion technique, FDA cleared for 10 days use in situ.
- QFlow 500 Single Lumen Bolt Kit Titanium bolt kit that secures the QFlow 500 Perfusion Probe through a small burr hole in the cranium; includes drill bit, depth collar, hex wrench, and dura piercer.
- QFlow 500 Dual Lumen Bolt Kit Titanium bolt kit that secures the QFlow 500 Perfusion Probe and one additional sensor through a burr hole for dual-port multimodal monitoring.
- QFlow 500 Quad Lumen Bolt Kit Titanium bolt kit that individually secures the QFlow 500 Perfusion Probe and three other sensors through one burr hole, enabling monitoring of up to six intracranial parameters.
Quantifiable outcome
- Thermal diffusion flowmetry reliably detects development of vasospasm-associated hypoperfusion with defined diagnostic cutoff values and predictive values
- +3 more outcomes
Companies that use Hemedex
Customer profileNamed customers17 records
Segments4 records
Ideal customer profiles3 records
Hemedex technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration7 records
Feature6 records
Hemedex partnerships and signals
Strategic signalPartnerships
Eleven partnerships are on record, tiered core and flagship.
- ICU Pilot (M-Dialysis)coreICU Pilot by M-Dialysis integrates with the Bowman Perfusion Monitor via digital output for comprehensive multimodal monitoring data collection and analysis.
- CNS TechnologiescoreCNS System by CNS Technologies interfaces with Hemedex BPM via digital output to integrate cerebral blood flow data into CNS monitoring platform.
- Excel Medical (Bedmaster)coreBedmaster by Excel Medical integrates with Hemedex BPM via digital output for ICU data acquisition and waveform review.
- University of Cambridge (ICM+)coreICM+ software from University of Cambridge interfaces with Hemedex BPM via digital output for research-grade multimodal monitoring and autoregulation assessment.
- PhilipscoreHemedex BPM analog output interfaces with Philips patient monitors using VueLink for integrated bedside display.
- Neurocritical Care SocietyflagshipHemedex is a featured exhibitor at NCS Annual Meeting (2022-2025) and sponsors educational content including the lunch symposium 'Pressure, Volume, and Flow: Filling in the Missing Piece of Brain Physiology in Multimodality Neuromonitoring' presented by Dr. Brandon Foreman.
- RaumediccoreRaumedic neurocritical care products including Neurovent ICP sensors are compatible with Hemedex Dual and Quad Lumen Bolt Kits for combined monitoring.
- Integra LifeSciencescoreIntegra Licox brain tissue oxygen and temperature probes are compatible with Hemedex Dual and Quad Lumen Bolt Kits for multimodal intracranial monitoring.
- Natus MedicalcoreNatus Camino ICP sensors are compatible with Hemedex Dual Lumen Bolt Kit for combined perfusion and ICP monitoring.
- CodmancoreCodman Microsensor ICP probes are compatible with Hemedex Single Lumen Bolt Kit for combined monitoring solutions.
- SophysacoreSophysa ICP sensors (PSO-PTT) are compatible with Hemedex Single Lumen Bolt Kit for multimodal monitoring.
Scale indicators6 records
Recent moves6 records
Expansion highlights5 records
Hemedex competitors and assessment
Company assessmentBroad incumbents
- Medtronic: Medtronic offers a broad portfolio of neuromonitoring and neurosurgery products including ICP monitors and BIS; a much larger incumbent whose portfolio overlaps with Hemedex in neurocritical care, often through partnerships or as a potential acquirer.
Direct peers
- Natus Medical: Natus produces the Camino intracranial pressure monitor, a competing invasive cranial monitoring technology; Hemedex Dual Lumen Bolt Kits are explicitly compatible with Natus Camino sensors, signaling direct overlap in neuro ICU monitoring.
- Spiegelberg: Spiegelberg produces intracranial pressure monitors and related neurosurgical devices, directly comparable to Hemedex's bolt-based monitoring platform for the neurocritical care market.
- Compumedics: Compumedics manufactures EEG and neurological monitoring systems used in neuro ICUs and research; its neuromonitoring portfolio overlaps with Hemedex's multimodal brain monitoring use case.
- Raumedic: Raumedic manufactures Neurovent ICP sensors and other cranial monitoring devices used in neuro ICUs; the company partners with Hemedex on Bolt Kit compatibility and competes in the broader intracranial monitoring category.
- Sophysa: Sophysa manufactures ICP sensors (including the PSO-PTT) used in neurocritical care. Hemedex Single Lumen Bolt Kits are designed for use with Sophysa probes, indicating both partnership and direct competition in invasive neuromonitoring.
- Integra LifeSciences: Integra's Licox product line offers brain tissue oxygen and temperature monitoring for neurocritical care, directly competing with Hemedex's cerebral perfusion offering as part of the multimodal neuromonitoring stack used alongside Hemedex Bolt Kits.
Emerging players
- M Dialysis (ICU Pilot): M Dialysis produces ICU Pilot, a multimodal neuromonitoring data platform that integrates with the Hemedex Bowman Perfusion Monitor. While primarily a software/analytics partner, the broader M Dialysis portfolio addresses adjacent neurocritical care monitoring use cases.
Others
- Edwards Lifesciences: Edwards is a global leader in hemodynamic monitoring (e.g., Swan-Ganz, FloTrac). While focused on cardiovascular rather than cerebral hemodynamics, it represents an adjacent monitoring paradigm and a potential strategic acquirer for perfusion-monitoring capabilities.
- Masimo: Masimo offers cerebral oximetry (O3) and other non-invasive patient monitoring technologies that address similar clinical needs (brain oxygenation/perfusion assessment) via a non-invasive modality, positioning it as a competing paradigm to invasive perfusion probes.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Hemedex social profiles
Digital presenceHemedex compliance and trust
Trust signalCompliance1 record
Hemedex financial estimates
Financial estimateRevenue estimate
Valuation estimate
Hemedex leadership team
Management profileNumber of profiles
Profiles8 records
Hemedex funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Hemedex M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Hemedex
What does Hemedex do?
Hemedex sells the Bowman Perfusion Monitor (BPM), a capital device that continuously quantifies tissue blood flow (perfusion) in absolute physiological units of ml/100g-min via proprietary thermal diffusion technology, together with its single-patient-use QFlow 500 Perfusion Probe and Single, Dual, and Quad Lumen Titanium Bolt Kits for cranial fixation. The system is used by neurosurgeons, neurointensivists, and neurologists in Neuro ICUs and operating rooms to detect cerebral ischemia, vasospasm, and edema in patients with traumatic brain injury, subarachnoid hemorrhage, and other acute brain injuries, and integrates with leading multimodal neuromonitoring platforms.
Is Hemedex a public or private company?
Hemedex is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Hemedex founded?
Hemedex was founded in 2000. It employs 11 to 50 people.
Where is Hemedex based?
Hemedex is headquartered in Cambridge, United States, in the North America region.
How does Hemedex make money?
One revenue line is on record: medical Device Hardware Sales.
Who are Hemedex's main competitors?
Medtronic is listed as a broad incumbent. Direct peers are Natus Medical, Spiegelberg, Compumedics, Raumedic, Sophysa and Integra LifeSciences. M Dialysis (ICU Pilot) is listed as an emerging player. Others are Edwards Lifesciences and Masimo.
Does Hemedex have an API?
No public API is recorded for Hemedex.
What industry is Hemedex in?
Hemedex's product category is Neurocritical Care Perfusion Monitoring Devices. Its primary akta.pro industry code is HLAHAFAI, Hemodynamic Monitoring & Cardiac Diagnostics (Cath Lab, FFR/IVUS/OCT), with a secondary code of HLAKAIAG, Stroke & Vascular Neurology. Its NAICS code is 334510 and its SIC code is 3845.